The plaque modification devices market size has grown strongly in recent years. It will grow from $1.49 billion in 2025 to $1.62 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing atherosclerosis prevalence, growth in angioplasty procedures, aging population, rise in peripheral artery disease, advancement in interventional cardiology.
The plaque modification devices market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to AI-guided vascular imaging, expansion of complex vascular interventions, demand for safer procedures, growth in outpatient interventions, innovation in plaque removal devices. Major trends in the forecast period include minimally invasive plaque removal, precision atherectomy technologies, improved embolic protection, advanced catheter-based systems, reduced procedure time devices.
The increasing number of minimally invasive procedures is anticipated to drive the growth of the plaque modification devices market in the future. Minimally invasive procedures are medical or surgical methods that involve smaller incisions, less disruption to tissues, and reduced physical trauma when compared to traditional open surgery. The rise in such procedures is fueled by technological advancements such as high-definition imaging and robotic systems, which enhance precision, as well as growing patient preferences for quicker recovery and less scarring. Plaque modification devices contribute to the safety and efficiency of minimally invasive procedures by enabling accurate removal of arterial blockages and expanding treatment options for patients with complex vascular conditions. For example, in January 2024, Intuitive Surgical Inc., a US-based company specializing in robotic products, reported the placement of 415 da Vinci surgical systems (robotic systems that utilize minimally invasive techniques) in the fourth quarter of 2023, marking a 12% increase from 2022. Thus, the growth in minimally invasive procedures is fueling the expansion of the plaque modification devices market.
Leading companies in the plaque modification devices market are focusing on creating advanced solutions, including intravascular image-guided, catheter-based systems, to maintain a competitive advantage. Intravascular image-guided procedures use imaging technology to assist in guiding devices or instruments within blood vessels. For example, in August 2024, Avinger, a US-based medical device company, introduced the Pantheris LV image-guided directional atherectomy system, designed to treat peripheral artery disease (PAD) in larger vessels such as the superficial femoral and popliteal arteries. This system features unique capabilities such as faster plaque excision for efficient removal of obstructive tissue, a proprietary jog mechanism that improves plaque apposition, and an advanced guidewire management system to simplify the operation process.
In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Shockwave Medical Inc. for an undisclosed sum. This acquisition aims to strengthen Johnson & Johnson's cardiovascular portfolio by incorporating Shockwave's intravascular lithotripsy technology, which is designed to treat calcified arterial plaque. The company anticipates this move will generate at least $1 billion in annual sales and help address gaps in the treatment of coronary and peripheral artery diseases. Shockwave Medical Inc., also based in the US, specializes in developing and commercializing medical products for cardiovascular conditions, including plaque modification devices.
Major companies operating in the plaque modification devices market are Cardinal Health, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers, Philips Healthcare, Becton Dickinson, Stryker Corporation, Boston Scientific, Terumo Corporation, Edward Lifesciences Corporation, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, Cardiovascular Systems Inc. (CSI), ACIST Medical Systems Inc., Endologix Inc., Avinger Inc., SoundBite Medical Solutions Inc.
North America was the largest region in the plaque modification devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plaque modification devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the plaque modification devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the plaque modification devices market by increasing costs of imported catheters, imaging components, and precision instruments. Atherectomy and thrombectomy segments are most impacted, especially in North America and Europe. Despite cost challenges, tariffs have promoted localized manufacturing, alternative sourcing, and development of cost-optimized interventional devices.
The plaque modification devices market research report is one of a series of new reports that provides plaque modification devices market statistics, including plaque modification devices industry global market size, regional shares, competitors with a plaque modification devices market share, detailed plaque modification devices market segments, market trends and opportunities, and any further data you may need to thrive in the plaque modification devices industry. This plaque modification devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Plaque modification devices are medical tools and technologies designed to address atherosclerotic plaque accumulation in blood vessels. These devices are used in minimally invasive procedures to restore blood flow by removing, modifying, or managing plaque within the arteries, especially in cases of cardiovascular or peripheral artery diseases.
The primary types of plaque modification devices include atherectomy devices, thrombectomy devices, chronic total occlusion devices, and embolic protection devices. Atherectomy devices are specialized tools used to remove or reduce atherosclerotic plaque buildup in blood vessels, thus improving blood circulation. These devices are used to treat conditions such as coronary artery disease, peripheral artery disease, and neurovascular diseases, and are employed in various settings such as hospitals, ambulatory surgical centers, and other healthcare facilities.
The plaque modification devices market consists of sales of atherectomy devices, scoring balloons, cutting balloons, plaque excision systems, and rotational ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The plaque modification devices market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to AI-guided vascular imaging, expansion of complex vascular interventions, demand for safer procedures, growth in outpatient interventions, innovation in plaque removal devices. Major trends in the forecast period include minimally invasive plaque removal, precision atherectomy technologies, improved embolic protection, advanced catheter-based systems, reduced procedure time devices.
The increasing number of minimally invasive procedures is anticipated to drive the growth of the plaque modification devices market in the future. Minimally invasive procedures are medical or surgical methods that involve smaller incisions, less disruption to tissues, and reduced physical trauma when compared to traditional open surgery. The rise in such procedures is fueled by technological advancements such as high-definition imaging and robotic systems, which enhance precision, as well as growing patient preferences for quicker recovery and less scarring. Plaque modification devices contribute to the safety and efficiency of minimally invasive procedures by enabling accurate removal of arterial blockages and expanding treatment options for patients with complex vascular conditions. For example, in January 2024, Intuitive Surgical Inc., a US-based company specializing in robotic products, reported the placement of 415 da Vinci surgical systems (robotic systems that utilize minimally invasive techniques) in the fourth quarter of 2023, marking a 12% increase from 2022. Thus, the growth in minimally invasive procedures is fueling the expansion of the plaque modification devices market.
Leading companies in the plaque modification devices market are focusing on creating advanced solutions, including intravascular image-guided, catheter-based systems, to maintain a competitive advantage. Intravascular image-guided procedures use imaging technology to assist in guiding devices or instruments within blood vessels. For example, in August 2024, Avinger, a US-based medical device company, introduced the Pantheris LV image-guided directional atherectomy system, designed to treat peripheral artery disease (PAD) in larger vessels such as the superficial femoral and popliteal arteries. This system features unique capabilities such as faster plaque excision for efficient removal of obstructive tissue, a proprietary jog mechanism that improves plaque apposition, and an advanced guidewire management system to simplify the operation process.
In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Shockwave Medical Inc. for an undisclosed sum. This acquisition aims to strengthen Johnson & Johnson's cardiovascular portfolio by incorporating Shockwave's intravascular lithotripsy technology, which is designed to treat calcified arterial plaque. The company anticipates this move will generate at least $1 billion in annual sales and help address gaps in the treatment of coronary and peripheral artery diseases. Shockwave Medical Inc., also based in the US, specializes in developing and commercializing medical products for cardiovascular conditions, including plaque modification devices.
Major companies operating in the plaque modification devices market are Cardinal Health, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers, Philips Healthcare, Becton Dickinson, Stryker Corporation, Boston Scientific, Terumo Corporation, Edward Lifesciences Corporation, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, Cardiovascular Systems Inc. (CSI), ACIST Medical Systems Inc., Endologix Inc., Avinger Inc., SoundBite Medical Solutions Inc.
North America was the largest region in the plaque modification devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plaque modification devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the plaque modification devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the plaque modification devices market by increasing costs of imported catheters, imaging components, and precision instruments. Atherectomy and thrombectomy segments are most impacted, especially in North America and Europe. Despite cost challenges, tariffs have promoted localized manufacturing, alternative sourcing, and development of cost-optimized interventional devices.
The plaque modification devices market research report is one of a series of new reports that provides plaque modification devices market statistics, including plaque modification devices industry global market size, regional shares, competitors with a plaque modification devices market share, detailed plaque modification devices market segments, market trends and opportunities, and any further data you may need to thrive in the plaque modification devices industry. This plaque modification devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Plaque modification devices are medical tools and technologies designed to address atherosclerotic plaque accumulation in blood vessels. These devices are used in minimally invasive procedures to restore blood flow by removing, modifying, or managing plaque within the arteries, especially in cases of cardiovascular or peripheral artery diseases.
The primary types of plaque modification devices include atherectomy devices, thrombectomy devices, chronic total occlusion devices, and embolic protection devices. Atherectomy devices are specialized tools used to remove or reduce atherosclerotic plaque buildup in blood vessels, thus improving blood circulation. These devices are used to treat conditions such as coronary artery disease, peripheral artery disease, and neurovascular diseases, and are employed in various settings such as hospitals, ambulatory surgical centers, and other healthcare facilities.
The plaque modification devices market consists of sales of atherectomy devices, scoring balloons, cutting balloons, plaque excision systems, and rotational ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Plaque Modification Devices Market Characteristics
3. Plaque Modification Devices Market Supply Chain Analysis
4. Global Plaque Modification Devices Market Trends and Strategies
5. Plaque Modification Devices Market Analysis of End Use Industries
7. Global Plaque Modification Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Plaque Modification Devices Total Addressable Market (TAM) Analysis for the Market
9. Plaque Modification Devices Market Segmentation
10. Plaque Modification Devices Market Regional and Country Analysis
11. Asia-Pacific Plaque Modification Devices Market
12. China Plaque Modification Devices Market
13. India Plaque Modification Devices Market
14. Japan Plaque Modification Devices Market
15. Australia Plaque Modification Devices Market
16. Indonesia Plaque Modification Devices Market
17. South Korea Plaque Modification Devices Market
18. Taiwan Plaque Modification Devices Market
19. South East Asia Plaque Modification Devices Market
20. Western Europe Plaque Modification Devices Market
21. UK Plaque Modification Devices Market
22. Germany Plaque Modification Devices Market
23. France Plaque Modification Devices Market
24. Italy Plaque Modification Devices Market
25. Spain Plaque Modification Devices Market
26. Eastern Europe Plaque Modification Devices Market
27. Russia Plaque Modification Devices Market
28. North America Plaque Modification Devices Market
29. USA Plaque Modification Devices Market
30. Canada Plaque Modification Devices Market
31. South America Plaque Modification Devices Market
32. Brazil Plaque Modification Devices Market
33. Middle East Plaque Modification Devices Market
34. Africa Plaque Modification Devices Market
36. Plaque Modification Devices Market Competitive Landscape and Company Profiles
37. Plaque Modification Devices Market Other Major and Innovative Companies
40. Plaque Modification Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Plaque Modification Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses plaque modification devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for plaque modification devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plaque modification devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Atherectomy Devices; Thrombectomy Devices; Chronic Total Occlusion Devices; Embolic Protection Devices2) By Application: Coronary Artery Disease; Peripheral Artery Disease; Neurovascular Diseases
3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Laser Atherectomy Devices; Orbital Atherectomy Devices2) By Thrombectomy Devices: Mechanical Thrombectomy Devices; Aspiration Thrombectomy Devices; Manual Thrombectomy Devices; Hybrid Thrombectomy Devices
3) By Chronic Total Occlusion (CTO) Devices: CTO Crossing Guidewires; CTO Balloons; CTO Catheters; CTO Support Systems
4) By Embolic Protection Devices: Distal Protection Devices; Proximal Protection Devices; Filter-Based Embolic Protection Devices; Balloon-Based Embolic Protection Devices
Companies Mentioned: Cardinal Health; Johnson & Johnson; Abbott Laboratories; Siemens Healthineers; Philips Healthcare; Becton Dickinson; Stryker Corporation; Boston Scientific; Terumo Corporation; Edward Lifesciences Corporation; Teleflex Incorporated; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Asahi Intecc Co. Ltd.; AngioDynamics; Cardiovascular Systems Inc. (CSI); ACIST Medical Systems Inc.; Endologix Inc.; Avinger Inc.; SoundBite Medical Solutions Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Plaque Modification Devices market report include:- Cardinal Health
- Johnson & Johnson
- Abbott Laboratories
- Siemens Healthineers
- Philips Healthcare
- Becton Dickinson
- Stryker Corporation
- Boston Scientific
- Terumo Corporation
- Edward Lifesciences Corporation
- Teleflex Incorporated
- Merit Medical Systems Inc.
- MicroPort Scientific Corporation
- Asahi Intecc Co. Ltd.
- AngioDynamics
- Cardiovascular Systems Inc. (CSI)
- ACIST Medical Systems Inc.
- Endologix Inc.
- Avinger Inc.
- SoundBite Medical Solutions Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.62 Billion |
| Forecasted Market Value ( USD | $ 2.23 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
